Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 43 results.
User Information
Export Records
  1. 1.   A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
  2. Zhang, Zhiying; Hu, Kaiwen; Miyake, Kentaro; Kiyuna, Tasuku; Oshiro, Hiromichi; Wangsiricharoen, Sintawat; Kawaguchi, Kei; Higuchi, Takashi; Razmjooei, Sahar; Miyake, Masuyo; Chawla, Sant P; Singh,Shree Ram; Hoffman, Robert M
  3. Scientific reports. 2020, Nov 18; 10(1): 20105.
  1. 2.   NADPH oxidase 1 is highly expressed in human large and small bowel cancers
  2. Lu, Jiamo; Jiang, Guojian; Wu, Yongzhong; Antony, Smitha; Meitzler, Jennifer L; Juhasz, Agnes; Liu, Han; Roy, Krishnendu; Makhlouf, Hala; Chuaqui, Rodrigo; Butcher,Donna; Konaté, Mariam M; Doroshow, James H
  3. PloS one. 2020, May 19; 15(5): e0233208.
  1. 3.   Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
  2. Basudhar, Debashree; Miranda, Katrina M.; Wink, David; Ridnour, Lisa
  3. REDOX-ACTIVE THERAPEUTICS. 2016; : 377-403.
  1. 4.   Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
  2. Day, C. P.; Carter, J.; Bonomi, C.; Hollingshead, M.; Merlino, G.
  3. International Journal of Cancer. 2012, Jan; 130(1): 190-199.
  1. 5.   Faithful Markers of Circulating Cancer Stem Cells: Is CD133 Sufficient for Validation in Clinics?
  2. Crea, F.; Fornaro, L.; Masi, G.; Falcone, A.; Danesi, R.; Farrar, W.
  3. Journal of Clinical Oncology. 2011, Sep; 29(25): 3487-3488.
  1. 6.   Pharmacogenomics and cancer stem cells: a changing landscape?
  2. Crea, F.; Duhagon, M. A.; Farrar, W. L.; Danesi, R.
  3. Trends in Pharmacological Sciences. 2011, Aug; 32(8): 487-494.
  1. 7.   Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in Progeria
  2. Hernandez, L.; Roux, K. J.; Wong, E. S. M.; Mounkes, L. C.; Mutalif, R.; Navasankari, R.; Rai, B.; Cool, S.; Jeong, J. W.; Wang, H. H.; Lee, H. S.; Kozlov, S.; Grunert, M.; Keeble, T.; Jones, C. M.; Meta, M. D.,; Young, S. G.; Daar, I. O.; Burke, B.; Perantoni, A. O.; Stewart, C. L.
  3. Developmental Cell. 2010, Sep 14; 19(3): 413-425.
  1. 8.   Inhibition of Hypoxia Inducible Factor-1 alpha by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis
  2. Terzuoli, E.; Donnini, S.; Giachetti, A.; Iniguez, M. A.; Fresno, M.; Melillo, G.; Ziche, M.
  3. Clinical Cancer Research. 2010, Aug; 16(16): 4207-4216.
  1. 9.   Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells
  2. Nath, N.; Chattopadhyay, M.; Kodela, R.; Tian, S.; Vlismas, P.; Boring, D.; Crowell, J. A.; Kashfi, K.
  3. Biochemical Pharmacology. 2010, Jun; 79(12): 1759-1771.
  1. 10.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 11.   Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence-Data from a Randomized Clinical Trial
  2. Barry, E. L.; Sansbury, L. B.; Grau, M. V.; Ali, I. U.; Tsang, S.; Munroe, D. J.; Ahnen, D. J.; Sandler, R. S.; Saibil, F.; Gui, J.; Bresalier, R. S.; McKeown-Eyssen, G. E.; Burke, C.; Baron, J. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2726-2733.
  1. 12.   Bioactive Food Components, Inflammatory Targets, and Cancer Prevention
  2. Kim, Y. S.; Young, M. R.; Bobe, G.; Colburn, N. H.; Milner, J. A.
  3. Cancer Prevention Research. 2009 2(3): 200-208.
  1. 13.   The signatures of autozygosity among patients with colorectal cancer
  2. Bacolod, M. D.; Schemmann, G. S.; Wang, S.; Shattock, R.; Giardina, S. F.; Zeng, Z. S.; Shia, J. R.; Stengel, R. F.; Gerry, N.; Hoh, J.; Kirchhoff, T.; Gold, B.; Christman, M. F.; Offit, K.; Gerald, W. L.; Notterman, D. A.; Ott, J.; Paty, P. B.
  3. Cancer Research. 2008 68(8): 2610-2621.
  1. 14.   Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk
  2. Berndt, S. I.; Potter, J. D.; Hazra, A.; Yeager, M.; Thomas, G.; Makar, K. W.; Welch, R.; Cross, A. J.; Huang, W. Y.; Schoen, R. E.; Giovannucci, E.; Chan, A. T.; Chanock, S. J.; Peters, U.; Hunter, D. J.; Hayes, R. B.
  3. Human Molecular Genetics. 2008 17(17): 2665-2672.
  1. 15.   Proline oxidase, a p53-induced gene, targets COX-2/PGE(2) signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Phang, J. M.
  3. Oncogene. 2008 27(53): 6729-6737.
  1. 16.   Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Chatterjee, N.; Yeager, M.; Welch, R.; Chanock, S. J.; Weissfeld, J. L.; Schoen, R. E.; Hayes, R. B.
  3. Carcinogenesis. 2007, Sep; 28(9): 1965-1970.
  1. 17.   Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
  2. Leupold, J. H.; Yang, H. S.; Colburn, N. H.; Asangani, I.; Post, S.; Allgayer, H.
  3. Oncogene. 2007, Jul; 26(31): 4550-4562.
  1. 18.   15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain
  2. Kim, H. J.; Kim, J. Y.; Meng, Z. J.; Wang, L. H.; Liu, F.; Conrads, T. P.; Burke, T. R.; Veenstra, T. D.; Farrar, W. L.
  3. Cancer Research. 2007, Mar; 67(6): 2595-2602.
  1. 19.   SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases
  2. Thangaraju, M.; Gopal, E.; Martin, P. M.; Ananth, S.; Smith, S. B.; Prasad, P. D.; Sterneck, E.; Ganapathy, V.
  3. Cancer Research. 2006, Dec; 66(24): 11560-11564.
  1. 20.   Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors
  2. Habermann, J. K.; Roblick, U. J.; Luke, B. T.; Prieto, D. A.; Finlay, W. J. J.; Podust, V. N.; Roman, J. M.; Oevermann, E.; Schiedeck, T.; Homann, N.; Duchrow, M.; Conrads, T. P.; Veenstra, T. D.; Burt, S. K.; Bruch, H. P.; Auer, G.; Ried, T.
  3. Gastroenterology. 2006, Oct; 131(4): 1020-1029.
  1. 21.   Smad4 signalling in T cells is required for suppression of gastrointestinal cancer
  2. Kim, B. G.; Li, C. L.; Qiao, W. H.; Mamura, M.; Kasperczak, B.; Anver, M.; Wolfraim, L.; Hong, S.; Mushinski, E.; Potter, M.; Kim, S. J.; Fu, X. Y.; Deng, C. X.; Letterio, J. J.
  3. Nature. 2006, Jun; 441(7096): 1015-1019.
  1. 22.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 23.   Proline oxidase, a proapoptotic gene, is induced by troglitazone - Evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms
  2. Pandhare, J.; Cooper, S. K.; Phang, J. M.
  3. Journal of Biological Chemistry. 2006, JAN 27; 281(4): 2044-2052.
  1. 24.   Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Belousov, P. V.; Kuz'mina, K. E.; Radko, B. V.; Longpre, F.; Lagarkova, M. A.; Kadachigova, T. S.; Gurova, O. V.; Meshcheryakov, A. A.; Lichinitser, M. R.; Knuth, A.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. International Journal of Cancer. 2005, DEC 10; 117(5): 800-806.
  1. 25.   Identification of celecoxib-modulated proteomic targets in colon cancer cell line, HCT-116
  2. Lou, J. R.; Xiao, Z.; Stauffer, S.; Fatima, N.; Conrads, T.; Veenstra, T.; Greenwald, P.; Ali, I.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2750S-2750S.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel